The DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.
Newly diagnosed and relapsed follicular lymphoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
Open accessAbstract
M. Dreyling1, M. Ghielmini2, S. Rule3, G. Salles4, U. Vitolo5 & M. Ladetto6, on behalf of the ESMO Guidelines Committee* Department of Medicine III, University of Munich, Germany; Oncology Institute of Southern Switzerland, Ospedale San Giovanni, Bellinzona, Switzerland; Haematology, Peninsula School of Medicine, Plymouth, UK; Hospices Civils de Lyon, Centre Hospitalier Lyon-Sud, Service d’Hématologie & Université Claude Bernard Lyon-1, PierreBenite, France; Haematology, University-Hospital Città della Salute e della Scienza, Torino; Divisione di Ematologia, Azienda Ospedaliera Santi Antonio e Biagio e Cesare Arrigo, Alessandria, Italy
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cheson, B. D., Fisher, R. I., Barrington, S. F., Cavalli, F., Schwartz, L. H., Zucca, E., & Lister, T. A. (2014) · Journal of Clinical Oncology · doi:10.1200/jco.2013.54.8800 · Cited by 5,715
Coiffier, B., Osmanov, E. A., Hong, X., Scheliga, A. A. D. S., Mayer, J., Offner, F. C., Rule, S. A., Teixeira, A., Walewski, J. A., de Vos, S., et al. (2011) · The Lancet Oncology · doi:10.1016/s1470-2045(11)70150-4 · Cited by 2,741
Self-citationChimeric Antigen Receptor T Cells in Refractory B-Cell Lymphomas
Schuster, S. J., Svoboda, J., Chong, E. A., Nasta, S. D., Mato, A. R., Anak, Ö., Brogdon, J. L., Pruteanu-Malinici, I., Bhoj, V., Landsburg, D., et al. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1708566 · Cited by 1,860
Rummel, M. J., Niederle, N., Maschmeyer, G., Banat, G. A., von Grünhagen, U., Losem, C., Kofahl-Krause, D., Heil, G., Welslau, M., Balser, C., et al. (2013) · The Lancet · doi:10.1016/s0140-6736(12)61763-2 · Cited by 1,510
Hiddemann, W. (2005) · Blood · doi:10.1182/blood-2005-01-0016 · Cited by 1,320
PI3Kδ Inhibition by Idelalisib in Patients with Relapsed Indolent Lymphoma
Gopal, A. K., Kahl, B. S., de Vos, S., Wagner-Johnston, N. D., Schuster, S. J., Jurczak, W. J., Flinn, I. W., Flowers, C. R., Martin, P., Viardot, A., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1314583 · Cited by 1,069
Self-citationTilly, H., Gomes da Silva, M., Vitolo, U., Jack, A., Meignan, M., Lopez-Guillermo, A., Walewski, J., André, M., Johnson, P. W., Pfreundschuh, M., et al. (2015) · Annals of Oncology · doi:10.1093/annonc/mdv304 · Cited by 930
Self-citationCasulo, C., Byrtek, M., Dawson, K. L., Zhou, X., Farber, C. M., Flowers, C. R., Hainsworth, J. D., Maurer, M. J., Cerhan, J. R., Link, B. K., et al. (2015) · Journal of Clinical Oncology · doi:10.1200/jco.2014.59.7534 · Cited by 850
Obinutuzumab for the First-Line Treatment of Follicular Lymphoma
Marcus, R., Davies, A., Ando, K., Klapper, W., Opat, S., Owen, C., Phillips, E., Sangha, R., Schlag, R., Seymour, J. F., et al. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1614598 · Cited by 800
Self-citationFederico, M., Bellei, M., Marcheselli, L., Luminari, S., Lopez-Guillermo, A., Vitolo, U., Pro, B., Pileri, S., Pulsoni, A., Soubeyran, P., et al. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.21.3991 · Cited by 751
Brice, P., Bastion, Y., Lepage, E., Brousse, N., Haïoun, C., Moreau, P., Straetmans, N., Tilly, H., Tabah, I., & Solal-Céligny, P. (1997) · Journal of Clinical Oncology · doi:10.1200/jco.1997.15.3.1110 · Cited by 647
Dykewicz, C. A. (2001) · Clinical Infectious Diseases · doi:10.1086/321805 · Cited by 636
Follicular Lymphoma International Prognostic Index
Solal-Celigny, P. (2004) · Blood · doi:10.1182/blood-2003-12-4434 · Cited by 626
Pastore, A., Jurinovic, V., Kridel, R., Hoster, E., Staiger, A. M., Szczepanowski, M., Pott, C., Kopp, N., Murakami, M., Horn, H., et al. (2015) · The Lancet Oncology · doi:10.1016/s1470-2045(15)00169-2 · Cited by 618
Self-citationMarcus, R., Imrie, K., Solal-Celigny, P., Catalano, J. V., Dmoszynska, A., Raposo, J. C., Offner, F. C., Gomez-Codina, J., Belch, A., Cunningham, D., et al. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.13.5376 · Cited by 594
Leonard, J. P., Trneny, M., Izutsu, K., Fowler, N. H., Hong, X., Zhu, J., Zhang, H., Offner, F., Scheliga, A., Nowakowski, G. S., et al. (2019) · Journal of Clinical Oncology · doi:10.1200/jco.19.00010 · Cited by 434
Ardeshna, K. M., Qian, W., Smith, P., Braganca, N., Lowry, L., Patrick, P., Warden, J., Stevens, L., Pocock, C. F. E., Miall, F., et al. (2014) · The Lancet Oncology · doi:10.1016/s1470-2045(14)70027-0 · Cited by 395
Phosphatidylinositol 3-Kinase Inhibition by Copanlisib in Relapsed or Refractory Indolent Lymphoma
Dreyling, M., Santoro, A., Mollica, L., Leppä, S., Follows, G. A., Lenz, G., Kim, W. S., Nagler, A., Panayiotidis, P., Demeter, J., et al. (2017) · Journal of Clinical Oncology · doi:10.1200/jco.2017.75.4648 · Cited by 395
Self-citationReduced dose radiotherapy for local control in non-Hodgkin lymphoma: A randomised phase III trial
Lowry, L., Smith, P., Qian, W., Falk, S., Benstead, K., Illidge, T., Linch, D., Robinson, M., Jack, A., & Hoskin, P. (2011) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2011.05.013 · Cited by 386
Rituximab plus Lenalidomide in Advanced Untreated Follicular Lymphoma
Morschhauser, F., Fowler, N. H., Feugier, P., Bouabdallah, R., Tilly, H., Palomba, M. L., Fruchart, C., Libby, E. N., Casasnovas, R.-O., Flinn, I. W., et al. (2018) · New England Journal of Medicine · doi:10.1056/nejmoa1805104 · Cited by 373
Self-citationSchulz, H., Bohlius, J. F., Trelle, S., Skoetz, N., Reiser, M., Kober, T., Schwarzer, G., Herold, M., Dreyling, M., Hallek, M., et al. (2007) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djk152 · Cited by 362
Self-citationHuang, Y.-H., Hsiao, L.-T., Hong, Y.-C., Chiou, T.-J., Yu, Y.-B., Gau, J.-P., Liu, C.-Y., Yang, M.-H., Tzeng, C.-H., Lee, P.-C., et al. (2013) · Journal of Clinical Oncology · doi:10.1200/jco.2012.48.5938 · Cited by 326
Bachy, E., Seymour, J. F., Feugier, P., Offner, F., López-Guillermo, A., Belada, D., Xerri, L., Catalano, J. V., Brice, P., Lemonnier, F., et al. (2019) · Journal of Clinical Oncology · doi:10.1200/jco.19.01073 · Cited by 290
Self-citationHoskin, P. J., Kirkwood, A. A., Popova, B., Smith, P., Robinson, M., Gallop-Evans, E., Coltart, S., Illidge, T., Madhavan, K., Brammer, C., et al. (2014) · The Lancet Oncology · doi:10.1016/s1470-2045(14)70036-1 · Cited by 247
Hiddemann, W., Barbui, A. M., Canales, M. A., Cannell, P. K., Collins, G. P., Dürig, J., Forstpointner, R., Herold, M., Hertzberg, M., Klanova, M., et al. (2018) · Journal of Clinical Oncology · doi:10.1200/jco.2017.76.8960 · Cited by 240
Self-citationSchmatz, A.-I., Streubel, B., Kretschmer-Chott, E., Püspök, A., Jäger, U., Mannhalter, C., Tiemann, M., Ott, G., Fischbach, W., Herzog, P., et al. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2010.32.9193 · Cited by 231
Huet, S., Tesson, B., Jais, J.-P., Feldman, A. L., Magnano, L., Thomas, E., Traverse-Glehen, A., Albaud, B., Carrère, M., Xerri, L., et al. (2018) · The Lancet Oncology · doi:10.1016/s1470-2045(18)30102-5 · Cited by 227
Self-citationA simplified scoring system in de novo follicular lymphoma treated initially with immunochemotherapy
Bachy, E., Maurer, M. J., Habermann, T. M., Gelas-Dore, B., Maucort-Boulch, D., Estell, J. A., Van den Neste, E., Bouabdallah, R., Gyan, E., Feldman, A. L., et al. (2018) · Blood · doi:10.1182/blood-2017-11-816405 · Cited by 211
Self-citationMorschhauser, F., Radford, J., Van Hoof, A., Botto, B., Rohatiner, A. Z. S., Salles, G., Soubeyran, P., Tilly, H., Bischof-Delaloye, A., van Putten, W. L. J., et al. (2013) · Journal of Clinical Oncology · doi:10.1200/jco.2012.45.6400 · Cited by 206
Self-citationKahl, B. S., Hong, F., Williams, M. E., Gascoyne, R. D., Wagner, L. I., Krauss, J. C., Habermann, T. M., Swinnen, L. J., Schuster, S. J., Peterson, C. G., et al. (2014) · Journal of Clinical Oncology · doi:10.1200/jco.2014.56.5853 · Cited by 195
Trotman, J., Luminari, S., Boussetta, S., Versari, A., Dupuis, J., Tychyj, C., Marcheselli, L., Berriolo-Riedinger, A., Franceschetto, A., Julian, A., et al. (2014) · The Lancet Haematology · doi:10.1016/s2352-3026(14)70008-0 · Cited by 182
Self-citationFriedberg, J. W., Byrtek, M., Link, B. K., Flowers, C., Taylor, M., Hainsworth, J., Cerhan, J. R., Zelenetz, A. D., Hirata, J., & Miller, T. P. (2012) · Journal of Clinical Oncology · doi:10.1200/jco.2011.40.6546 · Cited by 179
Louissaint, A., Ackerman, A. M., Dias-Santagata, D., Ferry, J. A., Hochberg, E. P., Huang, M. S., Iafrate, A. J., Lara, D. O., Pinkus, G. S., Salaverria, I., et al. (2012) · Blood · doi:10.1182/blood-2012-05-429514 · Cited by 158
Vidal, L., Gafter‐Gvili, A., Salles, G., Dreyling, M. H., Ghielmini, M. E. G., Schmitz, S. H., Pettengell, R., Witzens‐Harig, M., & Shpilberg, O. (2011) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djr418 · Cited by 131
Self-citationJurinović, V., Metzner, B., Pfreundschuh, M. G., Schmitz, N., Wandt, H., Keller, U. B., Dreger, P., Dreyling, M. H., Hiddemann, W., Unterhalt, M., et al. (2018) · Transplantation and Cellular Therapy · doi:10.1016/j.bbmt.2018.03.022 · Cited by 99
Self-citationShadman, M., Li, H., Rimsza, L., Leonard, J. P., Kaminski, M. S., Braziel, R. M., Spier, C. M., Gopal, A. K., Maloney, D. G., Cheson, B. D., et al. (2018) · Journal of Clinical Oncology · doi:10.1200/jco.2017.74.5083 · Cited by 86
Sander, B., de Jong, D., Rosenwald, A., Xie, W., Balagué, O., Calaminici, M., Carreras, J., Gaulard, P., Gribben, J. G., Hagenbeek, A., et al. (2014) · Haematologica · doi:10.3324/haematol.2013.095257 · Cited by 69
Self-citationZucca, E., Rondeau, S., Vanazzi, A., Østenstad, B., Mey, U., Rauch, D., Wahlin, B. E., Hitz, F., Hernberg, M., Johansson, A., et al. (2019) · Blood · doi:10.1182/blood-2018-10-879643 · Cited by 68
Self-citationTaverna, C., Martinelli, G., Hitz, F., Mingrone, W. B., Pabst, T., Cevreska, L. A., del Giglio, A., Vanazzi, A., Laszlò, D., Raats, J., et al. (2015) · Journal of Clinical Oncology · doi:10.1200/jco.2015.61.3968 · Cited by 66
Self-citationMounier, M., Bossard, N., Remontet, L., Belot, A., Minicozzi, P., Angelis, R. D., Capocaccia, R., Iwaz, J., Monnereau, A., Troussard, X., et al. (2015) · The Lancet Haematology · doi:10.1016/s2352-3026(15)00155-6 · Cited by 47
Schaaf, M., Reiser, M., Borchmann, P., Engert, A., & Skoetz, N. (2012) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd007678.pub2 · Cited by 44
Cited by
Budde, L. E., Sehn, L. H., Matasar, M., Schuster, S. J., Assouline, S., Giri, P., Kuruvilla, J., Canales, M., Dietrich, S., Fay, K., et al. (2022) · The Lancet Oncology · doi:10.1016/s1470-2045(22)00335-7 · Cited by 461
Sehn, L. H., Bartlett, N. L., Matasar, M. J., Schuster, S. J., Assouline, S. E., Giri, P., Kuruvilla, J., Shadman, M., Cheah, C. Y., Dietrich, S., et al. (2025) · Blood · doi:10.1182/blood.2024025454 · Cited by 94
Sehn, L. H., Hübel, K., Luminari, S., Scholz, C. W., Salar, A., Paneesha, S., Wahlin, B. E., Panayiotidis, P., Lee, H.-P., Jiménez-Ubieto, A., et al. (2026) · The Lancet · doi:10.1016/s0140-6736(25)01778-7 · Cited by 25
Cassanello, G., Drill, E., Rivas-Delgado, A., Okwali, M., Isgor, I., Caron, P. C., Epstein-Peterson, Z., Ghione, P., Hamlin, P., Lue, J., et al. (2024) · Haematologica · doi:10.3324/haematol.2024.285600 · Cited by 3
Self-citation
Metadata
- Authors
- Dreyling, M., Ghielmini, M., Rule, S., Salles, G., Ladetto, M., Tonino, S. H., Herfarth, K., Seymour, J. F., & Jerkeman, M.
- Venue
- Annals of Oncology
- Publisher
- Elsevier BV
- Published
- 2021-03
- Volume
- 32
- Issue
- 3
- Pages
- 298-308
- ISSN
- 0923-7534 (ISSN-L)
- OpenAlex
- W4255164806
- Cited by
- 270
- References
- 41
- FWCI
- 20.02
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.